Occam Recruits CSO for Public Gene Therapy Company, Adverum
In February 2024, Occam recruited Romuald “Romu” Corbau, PhD as Chief Scientific Officer for Adverum Biotechnologies (Nasdaq: ADVM).
Corbau has over 25 years of life science experience, ranging from startups to global pharmaceutical companies in the United States and Europe. He joins Adverum from GenEdit, where he served as Chief Scientific Officer. Prior to joining GenEdit, Corbau progressed from Vice President of Research to Chief Scientific Officer at Freeline. Before GenEdit, Corbau was the Translational Lead at Spark Therapeutics and held various research positions at Pfizer, CISTIM in Belgium, and Children’s Hospital of Philadelphia.
Occam Global is an international life science executive search and leadership advisory firm dedicated to building management teams for innovative companies in the biotech, techbio, life sciences, and venture capital sectors. Our firm’s unique strength lies in our seamless access to elite talent, proven expertise in aligning exceptional business and scientific leaders with optimal opportunities, and a steadfast dedication to creating meaningful industry impact, guided by elevated ethics and enlightened aggression. Trusted by entrepreneurs, investors, and corporations worldwide, Occam Global is recognized as the premier partner for executive search and recruitment in the life sciences. Our success is rooted in establishing trust, cultivating and valuing relationships, and committing to serve as forthright and good-humored partners in realizing extraordinary ambitions.